English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Multimedia Press Releases
2022年のPolkadot(DOT)について知っておくべきこと
2022年のPolkadot(DOT)について知っておくべきこと
April 1 2022, 15:00 HKT
more details
What You Need to Know about Polkadot (DOT) in 2022
What You Need to Know about Polkadot (DOT) in 2022
April 1 2022, 14:00 HKT
more details
Marubeni, OPExPARK, Beyond Next Ventures and DENSO Collaborate to Promote DX in the Healthcare Industry
Marubeni, OPExPARK, Beyond Next Ventures and DENSO Collaborate to Promote DX in the Healthcare Industry
April 1 2022, 12:13 HKT
more details
昭和電工、2022年入社式訓示(要旨)
昭和電工、2022年入社式訓示(要旨)
April 1 2022, 13:00 HKT
more details
Outline of Showa Denko CEO Message to Newly-hired Employees
Outline of Showa Denko CEO Message to Newly-hired Employees
April 1 2022, 12:00 HKT
more details
Fullerton Fund Management appoints Ken Goh as Chief Investment Officer
Fullerton Fund Management appoints Ken Goh as Chief Investment Officer
April 1 2022, 15:30 HKT
more details
沛嘉医疗公布2021年全年业绩
沛嘉医疗公布2021年全年业绩
April 1 2022, 10:53 HKT
more details
沛嘉医疗公布2021年全年业绩
沛嘉医疗公布2021年全年业绩
April 1 2022, 10:53 HKT
more details
沛嘉医疗公布2021年全年业绩
沛嘉医疗公布2021年全年业绩
April 1 2022, 10:53 HKT
more details
沛嘉医疗公布2021年全年业绩
沛嘉医疗公布2021年全年业绩
April 1 2022, 10:53 HKT
more details
沛嘉医疗公布2021年全年业绩
沛嘉医疗公布2021年全年业绩
April 1 2022, 10:53 HKT
more details
TOYOTA GAZOO Racing Premieres GR Corolla
TOYOTA GAZOO Racing Premieres GR Corolla
April 1 2022, 09:36 HKT
more details
VOOPOO and ZOVOO Shine as Joint Exhibitors at the 2022 Malaysia Vape Show
VOOPOO and ZOVOO Shine as Joint Exhibitors at the 2022 Malaysia Vape Show
March 31 2022, 22:00 HKT
more details
Thought Leaders and Early Adopters of AI to Share Insights at the 35th Global Edition of #WorldAIShow Dubai
Thought Leaders and Early Adopters of AI to Share Insights at the 35th Global Edition of #WorldAIShow Dubai
March 31 2022, 21:12 HKT
more details
The Place Holdings and Stellar Lifestyle to Collaborate on Various Digital Initiatives to Shape the Future of Digital Media and Tap New Opportunities in the Digital Economy
The Place Holdings and Stellar Lifestyle to Collaborate on Various Digital Initiatives to Shape the Future of Digital Media and Tap New Opportunities in the Digital Economy
March 31 2022, 20:00 HKT
more details
瑞科生物正式登陸港交所,新佐劑技術加速疫苗創新迭代
瑞科生物正式登陸港交所,新佐劑技術加速疫苗創新迭代
March 31 2022, 16:31 HKT
more details
瑞科生物正式登陸港交所,新佐劑技術加速疫苗創新迭代
瑞科生物正式登陸港交所,新佐劑技術加速疫苗創新迭代
March 31 2022, 16:31 HKT
more details
瑞科生物正式登陸港交所,新佐劑技術加速疫苗創新迭代
瑞科生物正式登陸港交所,新佐劑技術加速疫苗創新迭代
March 31 2022, 16:31 HKT
more details
瑞科生物正式登陸港交所,新佐劑技術加速疫苗創新迭代
瑞科生物正式登陸港交所,新佐劑技術加速疫苗創新迭代
March 31 2022, 16:31 HKT
more details
2022년 Shiden(SDN)에 대해 알아야 할 사항
2022년 Shiden(SDN)에 대해 알아야 할 사항
March 31 2022, 16:00 HKT
more details
2022年のShiden Network(SDN)について知っておくべきこと
2022年のShiden Network(SDN)について知っておくべきこと
March 31 2022, 17:00 HKT
more details
What You Need to Know about Shiden (SDN) in 2022
What You Need to Know about Shiden (SDN) in 2022
March 31 2022, 16:00 HKT
more details
瑞科生物正式登陆港交所,新佐剂技术加速疫苗创新迭代
瑞科生物正式登陆港交所,新佐剂技术加速疫苗创新迭代
March 31 2022, 16:30 HKT
more details
瑞科生物正式登陆港交所,新佐剂技术加速疫苗创新迭代
瑞科生物正式登陆港交所,新佐剂技术加速疫苗创新迭代
March 31 2022, 16:30 HKT
more details
瑞科生物正式登陆港交所,新佐剂技术加速疫苗创新迭代
瑞科生物正式登陆港交所,新佐剂技术加速疫苗创新迭代
March 31 2022, 16:30 HKT
more details
瑞科生物正式登陆港交所,新佐剂技术加速疫苗创新迭代
瑞科生物正式登陆港交所,新佐剂技术加速疫苗创新迭代
March 31 2022, 16:30 HKT
more details
Avance Clinical墨爾本辦公室正式啟動
Avance Clinical墨爾本辦公室正式啟動
March 31 2022, 15:00 HKT
more details
Avance Clinical墨尔本办公室正式启动
Avance Clinical墨尔本办公室正式启动
March 31 2022, 15:00 HKT
more details
Avance Clinical Announces New Office Opening in Melbourne
Avance Clinical Announces New Office Opening in Melbourne
March 31 2022, 15:00 HKT
more details
ASEAN Ceramics Thailand 2022
ASEAN Ceramics Thailand 2022
March 31 2022, 13:35 HKT
more details
 ACN Search:
 
TrustCSI 3.0 Navigates the 'Belt and Road' and Empowers Global Enterprise's Digital Journey
 
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575